These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34653770)

  • 1. Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.
    Xu S; Sun L; Dick A; Zalloum WA; Huang T; Meuser ME; Zhang X; Tao Y; Cherukupalli S; Ding D; Ding X; Gao S; Jiang X; Kang D; De Clercq E; Pannecouque C; Cocklin S; Liu X; Zhan P
    Eur J Med Chem; 2022 Jan; 227():113903. PubMed ID: 34653770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.
    Zhang X; Sun L; Meuser ME; Zalloum WA; Xu S; Huang T; Cherukupalli S; Jiang X; Ding X; Tao Y; Kang D; De Clercq E; Pannecouque C; Dick A; Cocklin S; Liu X; Zhan P
    Eur J Med Chem; 2021 Dec; 226():113848. PubMed ID: 34592608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
    Wang L; Casey MC; Vernekar SKV; Do HT; Sahani RL; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Eur J Med Chem; 2020 Aug; 200():112427. PubMed ID: 32438252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74.
    Sahani RL; Diana-Rivero R; Vernekar SKV; Wang L; Du H; Zhang H; Castaner AE; Casey MC; Kirby KA; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33804121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.
    Sun L; Dick A; Meuser ME; Huang T; Zalloum WA; Chen CH; Cherukupalli S; Xu S; Ding X; Gao P; Kang D; De Clercq E; Pannecouque C; Cocklin S; Lee KH; Liu X; Zhan P
    J Med Chem; 2020 May; 63(9):4790-4810. PubMed ID: 32298111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
    Sun L; Huang T; Dick A; Meuser ME; Zalloum WA; Chen CH; Ding X; Gao P; Cocklin S; Lee KH; Zhan P; Liu X
    Eur J Med Chem; 2020 Mar; 190():112085. PubMed ID: 32066010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel HIV-1 capsid-targeting small molecules of the PF74 binding site.
    Wang L; Casey MC; Vernekar SKV; Sahani RL; Kankanala J; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Eur J Med Chem; 2020 Oct; 204():112626. PubMed ID: 32814250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators.
    Xu S; Sun L; Zalloum WA; Huang T; Zhang X; Ding D; Shao X; Jiang X; Zhao F; Cocklin S; De Clercq E; Pannecouque C; Dick A; Liu X; Zhan P
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors.
    Li J; Jiang X; Dick A; Prakash Sharma P; Chen CH; Rathi B; Kang D; Wang Z; Ji X; Lee KH; Cocklin S; Liu X; Zhan P
    Bioorg Med Chem; 2021 Oct; 48():116414. PubMed ID: 34562701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules.
    Vernekar SKV; Sahani RL; Casey MC; Kankanala J; Wang L; Kirby KA; Du H; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32316297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74.
    Saito A; Ferhadian D; Sowd GA; Serrao E; Shi J; Halambage UD; Teng S; Soto J; Siddiqui MA; Engelman AN; Aiken C; Yamashita M
    J Virol; 2016 Jun; 90(12):5808-5823. PubMed ID: 27076642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of low-molecular-weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability.
    Jiang X; Gao Z; Sharma PP; Kumar S; Rathi B; Ji X; Dai J; Xie M; Dong G; Xu S; De Clercq E; Pannecouque C; Dick A; Zhan P; Liu X
    J Med Virol; 2024 Apr; 96(4):e29594. PubMed ID: 38576317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
    Shi J; Zhou J; Shah VB; Aiken C; Whitby K
    J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.
    Zhou J; Price AJ; Halambage UD; James LC; Aiken C
    J Virol; 2015 Sep; 89(17):9068-79. PubMed ID: 26109731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex.
    Balasubramaniam M; Zhou J; Addai A; Martinez P; Pandhare J; Aiken C; Dash C
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Enantiomeric Resolution and Biological Evaluation of HIV Capsid Inhibition Activity for Racemic, (
    Ruddell S; Sugrue E; Memarzadeh S; Hellam LM; Wilson SJ; France DJ
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34206893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel PF74-like small molecules targeting the HIV-1 capsid protein: Balance of potency and metabolic stability.
    Wang L; Casey MC; Vernekar SKV; Sahani RL; Kirby KA; Du H; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Acta Pharm Sin B; 2021 Mar; 11(3):810-822. PubMed ID: 33777683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor.
    Shi J; Zhou J; Halambage UD; Shah VB; Burse MJ; Wu H; Blair WS; Butler SL; Aiken C
    J Virol; 2015 Jan; 89(1):208-19. PubMed ID: 25320302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing.
    Siddiqui MA; Saito A; Halambage UD; Ferhadian D; Fischer DK; Francis AC; Melikyan GB; Ambrose Z; Aiken C; Yamashita M
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators.
    Xu S; Sun L; Barnett M; Zhang X; Ding D; Gattu A; Shi D; Taka JRH; Shen W; Jiang X; Cocklin S; De Clercq E; Pannecouque C; Goldstone DC; Liu X; Dick A; Zhan P
    J Med Chem; 2023 Dec; 66(23):16303-16329. PubMed ID: 38054267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.